Akili Current Ratio 2022-2023 | AKLI

Akili current ratio from 2022 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Akili Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2023-12-31 $0.08B $0.01B 6.02
2023-09-30 $0.09B $0.01B 6.95
2023-06-30 $0.11B $0.01B 8.27
2023-03-31 $0.12B $0.01B 10.62
2022-12-31 $0.14B $0.01B 10.37
2022-09-30 $0.16B $0.01B 12.27
2022-06-30 $0.00B $0.01B 0.09
2022-03-31 $0.00B $0.01B 0.11
2021-12-31 $0.08B $0.01B 9.92
2021-09-30 $0.00B $0.00B 29.09
2021-06-30 $0.00B $0.00B 0.40
2021-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.019B $0.002B
Akili Interactive is a digital medicine company pioneering the development of cognitive treatments through game-changing technologies. The company's platform is powered by proprietary therapeutic engines designed to target cognitive impairment. Akili Interactive, formerly known as Roblox, is based in BOSTON, Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.354B 21.89
Inspire Medical Systems (INSP) United States $7.194B 0.00
IRhythm Technologies (IRTC) United States $3.483B 0.00
Axonics (AXNX) United States $3.401B 0.00
10x Genomics (TXG) United States $3.288B 0.00
Enovis (ENOV) United States $3.030B 23.02
Azenta (AZTA) United States $2.910B 237.18
Olink Holding AB (publ) (OLK) Sweden $2.840B 0.00
Hims & Hers Health (HIMS) United States $2.678B 0.00
Privia Health (PRVA) United States $2.167B 96.11
Schrodinger (SDGR) United States $1.733B 0.00
Omnicell (OMCL) United States $1.279B 31.30
Phreesia (PHR) United States $1.162B 0.00
Definitive Healthcare (DH) United States $0.823B 0.00
Standard BioTools (LAB) United States $0.708B 0.00
Fulgent Genetics (FLGT) United States $0.601B 0.00
Talkspace (TALK) United States $0.527B 0.00
Health Catalyst (HCAT) United States $0.353B 0.00
Clover Health Investments (CLOV) United States $0.337B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.328B 0.00
Pulmonx (LUNG) United States $0.281B 0.00
Butterfly Network (BFLY) United States $0.162B 0.00
American Well (AMWL) United States $0.153B 0.00
MSP Recovery (LIFW) United States $0.141B 0.00
P3 Health Partners (PIII) United States $0.141B 0.00
Augmedix (AUGX) United States $0.139B 0.00
Outset Medical (OM) United States $0.124B 0.00
TruBridge (TBRG) United States $0.118B 5.03
111 (YI) China $0.086B 0.00
SHL Telemedicine (SHLT) Israel $0.082B 0.00
Future Health ESG (FHLT) United States $0.073B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.048B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.035B 0.00
Movano (MOVE) United States $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.018B 0.00
CareCloud (CCLD) United States $0.017B 0.00
ETAO (ETAO) United States $0.015B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00